Regarding MS, evidence in two independent cohorts of RRMS patients demonstrated that the classically inhibitory CD3−CD56brightCD16− NK cells from RRMS patients have impaired expansion in response to IL-12, and severely diminished IFN-γ production compared to healthy control NK cells (50). The gene discussed is IFNG; the disease is relapsing-remitting multiple sclerosis.